AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 288: E37-E46, 2005. First published July 20, 2004; doi:10.1152/ajpendo.00240.2004
0193-1849/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/1/E37    most recent
00240.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Raj, D. S. C.
Right arrow Articles by Ferrando, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raj, D. S. C.
Right arrow Articles by Ferrando, A.

Glutamine kinetics and protein turnover in end-stage renal disease

Dominic S. C. Raj,1 Tomas Welbourne,4 Elizabeth A. Dominic,3 Debra Waters,2 Robert Wolfe,5 and Arny Ferrando5

1Divisions of Nephrology and 2Epidemiology and Preventive Medicine, University of New Mexico Health Sciences Center, Albuquerque; 3Albuquerque Academy, Albuquerque, New Mexico; 4Department of Physiology, Louisiana State University Health Sciences Center, Shreveport, Louisiana; and 5Department of Surgery, University of Texas Medical Branch, Galveston, Texas

Submitted 7 June 2004 ; accepted in final form 12 July 2004

Alanine and glutamine constitute the two most important nitrogen carriers released from the muscle. We studied the intracellular amino acid transport kinetics and protein turnover in nine end-stage renal disease (ESRD) patients and eight controls by use of stable isotopes of phenylalanine, alanine, and glutamine. The amino acid transport kinetics and protein turnover were calculated with a three-pool model from the amino acid concentrations and enrichment in the artery, vein, and muscle compartments. Muscle protein breakdown was more than synthesis (nmol·min–1·100 ml leg–1) during hemodialysis (HD) (169.8 ± 20.0 vs. 125.9 ± 21.8, P < 0.05) and in controls (126.9 ± 6.9 vs. 98.4 ± 7.5, P < 0.05), but synthesis and catabolism were comparable pre-HD (100.7 ± 15.7 vs. 103.4 ± 14.8). Whole body protein catabolism decreased by 15% during HD. The intracellular appearance of alanine (399.0 ± 47.1 vs. 243.0 ± 34.689) and glutamine (369.7 ± 40.6 vs. 235.6 ± 27.5) from muscle protein breakdown increased during dialysis (nmol·min–1·100 ml leg–1, P < 0.01). However, the de novo synthesis of alanine (3,468.9 ± 572.2 vs. 3,140.5 ± 467.7) and glutamine (1,751.4 ± 82.6 vs. 1,782.2 ± 86.4) did not change significantly intradialysis (nmol·min–1·100 ml leg–1). Branched-chain amino acid catabolism (191.8 ± 63.4 vs. –59.1 ± 42.9) and nonprotein glutamate disposal (347.0 ± 46.3 vs. 222.3 ± 43.6) increased intradialysis compared with pre-HD (nmol·min–1·100 ml leg–1, P < 0.01). The mRNA levels of glutamine synthase (1.45 ± 0.14 vs. 0.33 ± 0.08, P < 0.001) and branched-chain keto acid dehydrogenase-E2 (3.86 ± 0.48 vs. 2.14 ± 0.27, P < 0.05) in the muscle increased during HD. Thus intracellular concentrations of alanine and glutamine are maintained during HD by augmented release of the amino acids from muscle protein catabolism. Although muscle protein breakdown increased intradialysis, the whole body protein catabolism decreased, suggesting central utilization of amino acids released from skeletal muscle.

amino acids; protein catabolism; nitrogen carriers; hemodialysis



Address for reprint requests and other correspondence: D. S. C. Raj, Div. of Nephrology, 5th Floor ACC, 2211 Lomas Blvd. NE, Albuquerque, NM 87131-5271 (E-mail: draj{at}salud.unm.edu)




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
G. C Ligthart-Melis, M. C. van de Poll, P. G Boelens, C. H. Dejong, N. E. Deutz, and P. A. van Leeuwen
Glutamine is an important precursor for de novo synthesis of arginine in humans
Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1282 - 1289.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
M. C. G. van de Poll, G. C. Ligthart-Melis, P. G. Boelens, N. E. P. Deutz, P. A. M. van Leeuwen, and C. H. C. Dejong
Intestinal and hepatic metabolism of glutamine and citrulline in humans
J. Physiol., June 1, 2007; 581(2): 819 - 827.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
D. S. C. Raj, O. Adeniyi, E. A. Dominic, M. A. Boivin, S. McClelland, A. H. Tzamaloukas, N. Morgan, L. Gonzales, R. Wolfe, and A. Ferrando
Amino acid repletion does not decrease muscle protein catabolism during hemodialysis
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1534 - E1542.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. J. M. Cano, D. Fouque, and X. M. Leverve
Application of Branched-Chain Amino Acids in Human Pathological States: Renal Failure
J. Nutr., January 1, 2006; 136(1): 299S - 307S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.